Wednesday, January 27, 2021

Single-dose vaccine passes early-stage international safety trials

The company is studying whether a second dose increases efficacy or durability of the immune response.

Other News

South Korean giant announces first overseas plant in Malaysia in another major pandemic-season investment

The Sabah plant will cater to the increasing global demand for copper foil which is crucial for electric vehicle batteries.

Gantung Parlimen, Anwar cabar PM di mahkamah

Anwar, selaku pemohon memfailkan permohonan itu di Mahkamah Tinggi Kuala Lumpur semalam menerusi Tetuan Karpal Singh & Co.

Pemimpin kanan DAP selar Noor Hisham

Ketua pengarah kesihatan itu didakwa menunjukkan kelemahannya dalam perang melawan Covid-19.

DAP leader hits out at Noor Hisham over ‘personal preferences’, ‘blind spots’

Liew Chin Tong criticises the DG for cautioning against the use of rapid test kits, adding that the government has 'practically abandoned' contact tracing as well.

Pasangan ‘PJJ’ boleh rentas negeri mulai esok, kata menteri

Kerajaan bersetuju memberi kelonggaran itu tetapi pasangan terbabit perlu mendapat kebenaran polis terlebih dahulu.

Johnson & Johnson’s single-dose experimental coronavirus vaccine has shown it generated an immune response in early-stage trials in nearly all volunteers, with minimal side effects, after a single dose, reports CNN.

The American company expects to report details of more advanced trials later this month and is hoping to apply for emergency authorisation from the US Food and Drug Administration (FDA) soon after.

Writing in the New England Journal of Medicine, an international team of researchers who tested the vaccine in around 800 volunteers said the early-stage trials showed it was safe and probably should work.

The FDA has given emergency use authorisation to the Pfizer-BioNTech and Moderna vaccines which were both about 95% effective in their Phase 3 trials. They use messenger RNA or mRNA, a new vaccine technology.

Johnson & Johnson’s vaccine arm, Janssen, uses a different technique for its vaccine, called for now by its experimental name, Ad26.COV2.S.

It uses a weakened version of a common cold virus called adenovirus 26 to carry genetic material from the virus into the body, prompting human cells to produce pieces of the virus which are then recognised by the immune system.

A company spokesman told CNN, “An efficacious single-dose Covid-19 vaccine has obvious logistic advantages over a two-dose vaccine, especially during a pandemic.”

The company is studying whether a second dose increases efficacy or durability of the immune response.

“If the single-dose vaccine is shown to be safe and effective, the company expects to submit an application for Emergency Use Authorisation with the FDA shortly afterwards, with other regulatory applications around the world to be made subsequently,” Johnson & Johnson said.

All of the companies making coronavirus vaccines have been manufacturing millions of doses even as they test them, so they can roll them straight out should they get FDA and international authorisation.

Johnson & Johnson is contracted to deliver 100 million doses to the US government if it wins EUA from the FDA.

Follow us on Telegram for the latest updates:

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles

Death toll hits 700 as recoveries still outstrip new cases

3,585 new cases, 4,076 recoveries with 280 in ICU.

Indonesia passes one million Covid-19 cases

There are reports of patients being unable to access ICUs and isolation rooms due to high demand – a shortage underscored by an East Java city's move to outfit a train carriage to accommodate the sick.

Philippine president tells kids to stay home and watch TV

Philippine President Rodrigo Duterte has reimposed a ban on children aged 10 to 14 leaving home, a move which others say could hamper economic recovery.

Tiger euthanised in Covid-19 outbreak at Swedish zoo

Three gorillas at a California zoo are recovering from the virus in what experts believe is the first known case of transmission to primates.

Rich and poor vaccine divide worsening, warns WHO

WHO emergencies director says only one disease – smallpox – has ever been eradicated, so the availability of vaccines against Covid-19 does not mean the disease can be wiped off the face of the Earth.